Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Achillion presents promising data from phase I MAD study of ACH-5228

July 23, 2019

Mimicking bone marrow keeps cultured blood stem cells quiescent

July 18, 2019

Finding MDS' iron fist

July 17, 2019

Activity maintained for recombinant factor VIII modified to extend half-life: MG-1121

July 16, 2019

Bodyweight-adjusted rivaroxaban treatment in children with acute venous thromboembolism

July 15, 2019

New CRISPR/Cas9 transgenic mice with mutated F8 gene as a model for the study of hemophilia A

July 15, 2019

Researchers develop CRISPR/Cas9 hemophilia A murine model

July 11, 2019

Phase I/II data presented for BIVV-001 in hemophilia A

July 10, 2019

Shanghai Meiyue Biotech presents new thrombin inhibitors

July 2, 2019

BioCryst opens enrollment in phase I study of oral factor D inhibitor BCX-9930

June 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...